Mirabegron + Solifenacin

Information about Mirabegron + Solifenacin

Mirabegron + solifenacin uses

Mirabegron+Solifenacin is used in the treatment of Overactive bladder (OAB) symptoms.

How mirabegron + solifenacin works

This is a combination of two medicines: Mirabegron and Solifenacin. Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. Solifenacin is an antimuscarinic. It also works by relaxing muscles of the urinary bladder. In this way, it works to prevent frequent, urgent, or uncontrolled urge of urination.

Common side effects of mirabegron + solifenacin

High blood pressure, Nasopharyngitis (inflammation of the throat and nasal passages), Urinary tract infection, Headache, Dryness in mouth, Constipation, Blurred vision, Dry eye, Urinary retention, Upper respiratory tract infection, Joint pain, Diarrhea, Abdominal pain, Fatigue, Tachycardia, Influenza, Dizziness, Palpitations, Glaucoma, Pain in urinary bladder, Kidney stone, Pharyngitis, Lower limb edema, Depression

Available Medicine for Mirabegron + Solifenacin

  • ₹385 to ₹605
    Lupin Ltd
    3 variant(s)
  • ₹344 to ₹461
    Walron Healthcare Pvt Ltd
    2 variant(s)
  • ₹262 to ₹352
    Intas Pharmaceuticals Ltd
    2 variant(s)
  • ₹453 to ₹605
    Lupin Ltd
    2 variant(s)
  • ₹352 to ₹504
    Leeford Healthcare Ltd
    2 variant(s)
  • ₹560
    Meddroid Pharmaceuticals Pvt Ltd
    1 variant(s)
  • ₹550
    Fawn Incorporation
    1 variant(s)
  • ₹290
    Daxia Healthcare
    1 variant(s)
  • ₹286 to ₹600
    Alembic Pharmaceuticals Ltd
    4 variant(s)
  • ₹453 to ₹578
    Ipca Laboratories Ltd
    4 variant(s)

Content on this page was last updated on 24 August, 2021, by Dr. Varun Gupta (MD Pharmacology)